The dose escalation approach used in research settings typically follows a structured stepwise pattern: Starting dose: A low dose (e.g., 12 mg once weekly) for the initial weeks Intermediate doses: Gradual increases at protocol-specified intervals Maintenance dose: A target dose determined by tolerability and clinical response It is important to note that, as retatrutide is not yet approved for clinical use in the UK, there is currently no officially recommended dosing regimen for patients outside of clinical trial settings
Ognard J, Douri D, El Hajj G et al (2025) Future is Ven(o)us: A 5-year narrative update on the venous route for therapeutics in neurointervention
The trial met its primary endpoint, with all doses shown to be safe and well-tolerated with no serious adverse events
You will receive tracking information via email once your GLP-3RT order ships
Fever accompanying diarrhea
Obese women experience a decrease in the magnitude of prolactin bursts after significant weight loss, whereas the frequency of bursts remains unchanged
